Article
4’-fluorouridine as a potential COVID-19 oral drug?: a review
2023-05-22
Abstract excerpt
The available antiviral drugs against coronavirus disease 2019 (COVID-19) are limited. Oral drugs that can be prescribed to non-hospitalized patients are required. The 4′-fluoruridine, a nucleoside analog similar to remdesivir, is one of the promising candidates for COVID-19 oral therapy due to its ability to stall viral RdRp. Available data suggested that 4'-fluorouridine has antiviral activity against the respir...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ef7c7756-6568-5654-a245-08a80027b252
- DOI
- 10.12688/f1000research.109701.2
